8 withdrawn. 8 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Withdrawn 8 |
| Phase 3 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss SPI-1005 200mg, SPI-1005 400mg, Placebo - Noise Induced Hearing Loss | Phase 2 | Withdrawn | Sound Pharmaceuticals, Incorporated | 2026-06-01 | 2026-06-03 | |
| Repurposing the Antipsychotic Drug Chlorpromazine as Adjuvant Therapeutic Agent for Resected Stage III Colon Cancer ChlorproMAZINE 50 MG, Control - Colon Cancer Stage III | Phase 1 / Phase 2 | Withdrawn | Sadat City University | 2022-07-20 | 2022-10-27 | |
| Topical CBD for Musculoskeletal Pain CBD, Control - Musculoskeletal Pain | Phase 2 / Phase 3 | Withdrawn | University of Virginia | 2022-01-01 | 2024-02-28 | |
| Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures Mitomycin C, Control - Esophageal Stenosis, Anastomotic Stenosis | Phase 2 | Withdrawn | Fox Chase Cancer Center | 2020-04-03 | 2022-04-11 | |
| Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients Probiotic Formula Capsule, Control - Colorectal Cancer | Phase 2 / Phase 3 | Withdrawn | King Hussein Cancer Center | 2018-11-07 | 2023-03-15 | |
| Naloxegol for Opioid-Related Gastroparesis Naloxegol 25 MG Oral Tablet [Movantik], Placebo Oral Tablet - Gastroparesis, Opioid Use | Phase 2 | Withdrawn | Temple University | 2016-12-29 | 2020-08-27 | |
| Phase 2c Dose Comparison Study of MP4OX in Trauma MP4OX, Control - Trauma, Hemorrhagic Shock | Phase 2 | Withdrawn | Sangart | 2013-12-01 | 2013-10-31 | |
| A Network Intervention for Prevention of HIV Infection in Chennai, India - 1 psychoeducational, control - HIV Infections | Phase 2 | Withdrawn | Johns Hopkins Bloomberg School of Public Health | 2003-01-01 | 2022-09-21 |
Acidosis, Lactic (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Stenosis (1) · Gastroparesis (1) · HIV Infections (1) · Hearing Loss, Noise-Induced (1) · Hemorrhage (1) · Musculoskeletal Pain (1) · Shock, Hemorrhagic (1) · Wounds and Injuries (1)
Fox Chase Cancer Center (1) · Johns Hopkins Bloomberg School of Public Health (1) · King Hussein Cancer Center (1) · Sadat City University (1) · Sangart (1) · Sound Pharmaceuticals, Incorporated (1) · Temple University (1) · University of Virginia (1)
United States (4) · Australia (1) · Belgium (1) · Brazil (1) · Egypt (1) · France (1) · Germany (1) · India (1) · Israel (1) · Jordan (1) · New Zealand (1) · Norway (1) · South Africa (1) · Switzerland (1) · United Kingdom (1)
Brent DeGeorge, MD, PhD (1) · Carl Latkin, Ph.D. (1) · Fawzi Abuhijla, MD,MSc (1) · Frank V. Booth, BCh, FACS (1) · Henry Parkman, MD (1) · Jonathan Kil, MD (1) · Karim Brohi, MD (1) · Lana M Agraib, PhD (1)